Form 4/A for ANGO ANGIODYNAMICS INC
Accepted 2021-08-18 00:00:00 ET · period of report 2021-08-12 · accession 0001567619-21-016025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2021-08-18 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $0.00 | +8,210 | 34.9K | +31% | $0 |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $27.29 | -3,130 | 31.7K | -9% | -$85.4K |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $0.00 | -7,079 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-12 | M | A | 8,210 | $0.00 | 34,871 | D | — | — | (F1) On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold. (F2) This acquisition of 8,210 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018. |
| 2 | Common | Common Stock | 2021-08-12 | F | D | 3,130 | $27.29 | 31,741 | D | — | — | (F1) On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold. (F3) The exempt disposition of 3,130 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018. |
| 3 | Derivative | Performance Right | 2021-08-12 | M | D | 7,079 | $0.00 | 0 | D | — · — to — | 7,079 Common Stock | (F4) On July 18, 2018, the reporting person received a target grant of 7,079 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 8,210 shares of Common Stock were issued to the reporting person under this grant. |